MedPath

重庆吉斯瑞制药有限责任公司

Ownership
-
Established
2020-06-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

35

NMPA:35

Drug Approvals

Cefdinir Granules

Product Name
头孢地尼颗粒
Approval Number
国药准字H20253773
Approval Date
Apr 1, 2025
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H20253663
Approval Date
Mar 18, 2025
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
注射用头孢哌酮钠舒巴坦钠
Approval Number
国药准字H20258025
Approval Date
Mar 5, 2025
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20249268
Approval Date
Nov 5, 2024
NMPA

Rifampicin for Injection

Product Name
注射用利福平
Approval Number
国药准字H20244279
Approval Date
Jun 28, 2024
NMPA

Latamoxef Sodium for Injection

Product Name
注射用拉氧头孢钠
Approval Number
国药准字H20233673
Approval Date
Jun 7, 2023
NMPA

Latamoxef Sodium for Injection

Product Name
注射用拉氧头孢钠
Approval Number
国药准字H20233674
Approval Date
Jun 7, 2023
NMPA

Cefmetazole Sodium

Product Name
头孢美唑钠
Approval Number
国药准字H20070221
Approval Date
Apr 18, 2022
NMPA

Clindamycin Hydrochloride for Injection

Product Name
注射用盐酸克林霉素
Approval Number
国药准字H20110002
Approval Date
Oct 10, 2020
NMPA

Sodium Thiosulfate Injection

Product Name
硫代硫酸钠注射液
Approval Number
国药准字H50020771
Approval Date
Sep 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.